Exchange: NASDAQ Sector: Healthcare Industry: Medical Devices
Current Signal: SELL (auto-tracking)
-1.57% $16.91
America/New_York / 17 apr 2024 @ 16:00
FUNDAMENTALS | |
---|---|
MarketCap: | 686.55 mill |
EPS: | 0.990 |
P/E: | 17.08 |
Earnings Date: | Apr 30, 2024 |
SharesOutstanding: | 40.60 mill |
Avg Daily Volume: | 0.337 mill |
RATING 2024-04-17 |
---|
B+ |
Neutral |
RATINGS | ||
---|---|---|
Rating CashFlow: | Buy | |
Return On Equity: | Sell | |
Return On Asset: | Neutral | |
DE: | Strong Buy | |
P/E: | Strong Sell | |
Price To Book: | Neutral |
QUARTER GROWTHS | ||||||
---|---|---|---|---|---|---|
3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
Revenue | ||||||
Gr.Profit | ||||||
Ebit | ||||||
Asset | ||||||
Debt |
PE RATIO: COMPANY / SECTOR |
---|
0.00x |
Company: PE 17.08 | sector: PE -3.05 |
PE RATIO: COMPANY / INDUSTRY |
---|
0.08x |
Company: PE 17.08 | industry: PE 222.16 |
DISCOUNTED CASH FLOW VALUE |
---|
$17.24 (1.92%) $0.325 |
Date: 2024-04-17 |
Expected Trading Range (DAY) |
---|
$ 16.49 - 17.33 ( +/- 2.50%) |
ATR Model: 14 days |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-15 | Honeysett Kimberley E. | Sell | 2 860 | Common Stock |
2024-02-15 | Sanyal Sunny | Buy | 30 223 | Common Stock |
2024-02-15 | Sanyal Sunny | Sell | 13 520 | Common Stock |
2024-02-15 | Sanyal Sunny | Sell | 30 223 | Restricted Stock Units |
2024-02-15 | Jonaitis Mark S. | Buy | 4 890 | Common Stock |
INSIDER POWER |
---|
20.51 |
Last 100 transactions |
Buy: 535 367 | Sell: 362 796 |
Indicator Signals | |
---|---|
RSI 21 | |
SMA | |
Trend | |
Trend 2 | |
Trend 3 | |
MACD |
Volume Signals | |
---|---|
Price | $16.91 (-1.57% ) |
Volume | 0.401 mill |
Avg. Vol. | 0.337 mill |
% of Avg. Vol | 118.84 % |
Signal 1: | |
Signal 2: |
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
Date | Signal | @ | Closed | % | Feb 8 - 15:35 | sell | $17.02 | N/A | Active |
---|
Varex Imaging Corporation designs and manufactures X-ray imaging components. The company operates in two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components comprising X-ray tubes, digital detectors, high voltage connectors, image-processing software and workstations, 3D reconstruction and computer-aided diagnostic software, collimators, automatic exposure control devices, generators, heat exchangers, ionization chambers, and buckys. This segment's products are used in a range of applications, including radiographic and fluoroscopic imaging, mammography, computed tomography, radiation therapy, oncology, CT, cardiac, surgery, dental, computer-aided detection, and other diagnostic radiography uses. The Industrial segment designs, manufactures, sells, and services Linatron X-ray accelerators, X-ray tubes, digital detectors, and high voltage connectors for use in security and industrial inspection applications, such as airport security, cargo screening at ports and borders, and nondestructive testing and examination in various applications. Varex Imaging Corporation sells its products through imaging system original equipment manufacturers, independent service companies, and distributors, as well as directly to end-users. The company has operations in North America, South America, Europe, Russia, the Middle East, India, Africa, Asia, and Australia. Varex Imaging Corporation was founded in 2016 and is based in Salt Lake City, Utah.